|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 880.2 INR | -0.32% |
|
-0.33% | +29.41% |
| 05-28 | Jenburkt Pharmaceuticals Limited Announces Board Retirements | CI |
| 05-28 | Jenburkt Pharmaceuticals Limited Announces Dividend | CI |
Jenburkt Pharmaceuticals Limited reported earnings results for the first quarter ended June 30, 2023. For the first quarter, the company reported sales was INR 291.75 million compared to INR 311.32 million a year ago. Revenue was INR 302.12 million compared to INR 322.75 million a year ago.
Net income was INR 53.69 million compared to INR 59.53 million a year ago. Basic earnings per share from continuing operations was INR 12.17 compared to INR 12.97 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +29.41% | 46.69M | |
| +56.86% | 823B | |
| +41.24% | 641B | |
| -6.57% | 352B | |
| +17.32% | 324B | |
| +9.94% | 301B | |
| +15.32% | 241B | |
| +1.60% | 223B | |
| +13.57% | 218B | |
| +7.98% | 167B |
JENBURKT PHARMACEUTICALS LIMITED 
